期刊文献+

不可切除胃癌转化治疗的研究进展 被引量:2

下载PDF
导出
摘要 胃癌居世界最常见肿瘤的第5位,是引起死亡的第三大肿瘤,全球每年新发胃癌病例约100万例,其中50%来自东亚。虽然同样是胃癌高发国家,韩国和日本因拥有较完善的胃癌国家早期筛查计划,故早期胃癌占比高,患者5年生存率也明显高于中国。在中国,以进展期胃癌为主,患者5年生存率〈40%。
出处 《上海医学》 北大核心 2017年第12期771-774,共4页 Shanghai Medical Journal
基金 国家自然科学基金(面上基金)资助(81472277)
  • 相关文献

参考文献2

二级参考文献49

  • 1Bang Y J,Van Cutsem E,Feyereislova A,et al.ToGA Trial Investigators.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer(ToGA):a phase 3,open-label,randomised controlled trial[J].Lancet,2010,376:687-697.
  • 2Van Cutsem E,KShne CH,Hitre E,et al.Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer[J].N Engl J Med,2009,360:1408-1417.
  • 3Fuchs CS,Tomasek J,Yong CJ,et al.REGARD Trial Investigators.Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD):an international,randomised,multicentre,placebo-controlled,phase 3 trial[J].Lancet,2014,383:31-39.
  • 4Yasuyama A,Mikata S,Soma Y,et al.Two cases of human epidermal growth factor receptor 2-positive advanced gastric cancer successfully treated with S-1,cisplatin,and trastuzumab combination therapy followed by curative resection[J].Gan To Kagaku Ryoho,2013,40:2203-2206.
  • 5Nakayama Y,Kawasaki H,Wajima N,et al.Two cases of stage Ⅳ gastric cancer treated by resection of the primary tumor after chemotherapy combined with trastuzumab[J].Gan To Kagaku Ryoho,2013,40:2188-2190.
  • 6Ikari N,Nakajima G,Taniguchi K,et al.HER2-positive gastric cancer with paraaortic nodal metastasis successfully resected after chemotherapy with trastuzumab:a case report[J].Anticancer Res,2014,34:867-872.
  • 7Hoffmann-La Roche.A study of capecitabine (Xeloda) in combination with trastuzumab (Herceptin) and oxaliplatin in patients with resectable gastric cancer[DB/OL].[2014-08-10].http://clinicaltrials.gov/show/N CT01130337.
  • 8National Cancer Institute (NCI.) Radiation therapy paclitaxel,and carboplatin with or without trastuzumab in treating patients with esophageal cancer (RTOG 1010 Trial)[DB/OL].[2014-08-10].http://clinicaltrials.gov/show/NCT01196390.
  • 9Hoffmann-La Roche.A study of the combination of oxaliplatin,capecitabine and Herceptin (trastuzumab) and chemoradiotherapy in the adjuvant setting in operated patients with HER2 + gastric or gastroesophageal junction cancer (TOXAG Study)[DB/OL].[2014-08-10].http://clinicaltrials.gov/show/NCT01748773.
  • 10Ye LC,Liu TS,Ren L,et al.Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wildtype unresectable colorectal liver-limited metastases[J].J Clin Oncol,2013,31:1931-1938.

共引文献24

同被引文献11

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部